Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary eventsSara Rattik, Maria Wigren, Harry Björkbacka, et al.
European Journal of Cardiovascular Nursing|July 8, 2026
Determinants of risk factor target attainment after myocardial infarction: the Perfect-CR studyHalldora Ögmundsdottir Michelsen, Peter Henriksson, John Wallert, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow ReserveTroels Yndigegn, Sasha Koul, Rebecca Rylance, et al.
European Heart Journal|July 12, 2019
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarctionGoran Marinković, Helena Grauen Larsen, Troels Yndigegn, et al.
European Journal of Preventive Cardiology|July 28, 2019
Cardiac rehabilitation after acute myocardial infarction in Sweden - evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) studyHalldora Ögmundsdottir Michelsen, Ingela Sjölin, Mona Schlyter, et al.
Helicobacter|March 16, 2026
Helicobacter pylori, Inflammation, and Long-Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort StudyMartin O Sundqvist, Jonatan Wärme, Marcus Hjort, et al.
Circulation. Heart Failure|November 8, 2024
IL1RAP Blockade With a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune MyocarditisDiego A Lema, Gabriel Jakobsson, Abdel Daoud, et al.
International Journal of Cardiology|September 11, 2022
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR studyHalldora Ögmundsdottir Michelsen, Peter Henriksson, John Wallert, et al.
Critical Care (London, England)|September 29, 2023
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunctionGabriel Jakobsson, Praveen Papareddy, Henrik Andersson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 2, 2021
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort studyTroels Yndigegn, Patrik Gilje, Josef Dankiewicz, et al.
Pageof 7